Search Results - "Bos, L.D."

Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis by Bos, L D, Schouten, L R, van Vught, L A, Wiewel, M A, Ong, D S Y, Cremer, O, Artigas, A, Martin-Loeches, I, Hoogendijk, A J, van der Poll, T, Horn, J, Juffermans, N, Calfee, C S, Schultz, M J

“…We hypothesised that patients with acute respiratory distress syndrome (ARDS) can be clustered based on concentrations of plasma biomarkers and that the…”
Get more information

The fragility of statistically significant findings in randomised controlled anaesthesiology trials: systematic review of the medical literature by Mazzinari, G, Ball, L, Serpa Neto, A, Errando, C L, Dondorp, A M, Bos, L D, Gama de Abreu, M, Pelosi, P, Schultz, M J

“…The fragility index (FI), the number of events the statistical significance a result depends on, and the number of patients lost to follow-up are important…”
Get more information

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia by Beenen, L.F.M., Bos, L.D., Scheerder, M.J., Lobé, N.H.J., Muller, M.C.A., Schultz, M.J., van den Aardweg, J.G., Goorhuis, A., Bonta, P.I., Middeldorp, S., Vlaar, A.P.

Get full text

High PEEP/low FiO2 ventilation is associated with lower mortality in COVID–19 by Goossen, Robin L., van Vliet, Relin, Buiteman-Kruizinga, Laura A., Hollman, Markus W., Myatra, Sheila N., van Meenen, David M.P., van Akkeren, J.P., Algoe, C.K., van Amstel, R.B., Bailey, M., van de Berg, P., Bergmans, D.C.J.J., Bevers, M., Bruna, C.L., Boers, L.S., Bogerd, M.B., Bos, L.D., Bosman, B., Botta, M., Baur, O.L., Buiteman-Kruizinga, L.A., Coene, W., Delmte, M., Determann, R.M., Di Leo, V., van Dijk, J., Dongelmans, D.A., Dormans, T., Endeman, H., Elting, L.M., Franke, H.S., Galek-aldridge, M.S., de Abreu, M.G. Gama, Girbes, A.R., Go, D.M., Goossen, R.L., de Graaff, M.J., Hagens, L.A., Hansen, H.J., Haringman, J.J., van der Heide, S.T., van der Heiden, P.L.J., Hoogendoorn, M.E., Horn, J., van der Horst, R., Huijben, J.A., Ie, E.L.K., van Ingen, L.E., Ivanov, D.P., Kranen, H.T., Kho, E., de Klerk, E.S., Koek, N., Gemert, A.W.M.M. Koopman-van, Koopmans, M., Kucukcelebi, S., Koornstra, E., Martin-Loeches, I., Mazzinari, G., Moeniralam, H., van Mourik, N., Offermans, M., Onrust, M., Oostdijk, E.A.N., Pennartz, C.J., Pisani, L., Pisters, T., Prins, A., Purmer, I.M., Rezaee, A.S., Roca, O., Roozeman, J., Rozendaal, J., Rosenberg, N.M., Sciascera, A., Schuijt, M.T.U., Shrestha, G.S., van Silfhout, B., Sleeswijk, M.E., van Smaalen, K.M., Smit, M.R., Spronk, P.E., Šribar, A., Stilma, W., Tuinman, P.R., Tsonas, A.M., Valk, C.M.A., van Velzen, P., Vermeulen, T.D., van Vliet, P., van der Voort, P.H.J., van Welie, L., Wesselink, H.J.F.T., van der Wier-Lubbers, H., van Willigen, H., van der Woude, M.C.E., Weiner, J.J., Wong, W.Y., van Zijl, T.Z.I., Zonneveld, S.A.

“…The positive end–expiratory pressure (PEEP) strategy in patients with coronavirus 2019 (COVID–19) acute respiratory distress syndrome (ARDS) remains debated…”
Get full text

ePS6.01 Targeted analysis of volatile organic compounds for detection of Pseudomonas aeruginosa in cystic fibrosis patients by exhaled breath analysis by Kos, R., Brinkman, P., Neerincx, A.H., Paff, T., Gerritsen, M.G., Lammers, A., Kraneveld, A.D., Heijerman, H.G.M., Davies, J.C., Janssens, H.M., Majoor, C.J., Weersink, E.J., Sterk, P.J., Haarman, E.G., Bos, L.D., Maitland-van der Zee, A.H.

Get full text

P047 Detection of Pseudomonas aeruginosa in exhaled breath of cystic fibrosis patients by Neerincx, A.H., Brinkman, P., van der Gouwe, P., Pfaff, T., Fens, N., Gerritsen, M., Haarman, E., van Aalderen, W.M.C., Majoor, C.J., Weersink, E.J.M., Bos, L.D., Sterk, P.J., Maitland-van der Zee, A.H.

Get full text